Here's Advertisement
Crocs (NASDAQ:CROX) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.
Other research analysts have also issued reports about the company. Pivotal Research set
BidaskClub upgraded shares of Centerstate Bank (NASDAQ:CSFL) from a hold rating to a buy rating in a research note published on Tuesday.
Several other equities research analysts have also commented on CSFL. ValuEngine lowered shares of Centerstate Bank from a hold rating to a sell rating
Question: I want to invest in an IRA in addition to my 401(k) so I can buy some individual stocks, but I make too much to qualify for the traditional IRA deduction or to make a Roth IRA contribution. Is it worth making a non-deductible traditional IRA contribution?
Answer: The short answer is “probably not.”
To bring readers up to speed, anyone who has earned income can....More>>>
When it comes to low-priced stocks, maybe it’s best to curb your derision. There are a lot of investments out there with single-digit price tags, and they’re not all speculative fodder for penny-stock gamblers to fight over. Stocks trading below $10 are naturally riskier than some of the more established choices out there, but there are also opportunities there for the taking if you’re....More>>>
Shares of Ivy ProShares Russell 2000 Dividend Growers Index Fund (NYSEARCA:FXP) are scheduled to reverse split on the morning of Thursday, May 24th. The 1-4 reverse split was announced on Wednesday, May 9th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, May 23rd.
Shares of NYSEARCA FXP opened at $14.57 on Friday.
Get....More>>>
Shares of Gap (GPS ) have climbed 10% over the last four weeks in a sign that investors might be anticipating strong quarterly financial results from the retailer. Let’s take a look to see what they should really expect from Gap in the first quarter.
Gap follows a slew of other retail industry giants which have all reported their quarterly earnings results over the last few weeks,....More>>>
By Greg Daugherty, Next Avenue Contributor
Nearly 60 years ago, a writer calling himself Bob Belmont published a modest little book with an immodest title: How to Retire Without Money! You arent likely to find it in your library, but you might come across a copy at a used book sale, as I did recently. I think I paid a quarter for it and it was worth every penny.
Credit: Shutterstock
Today,....More>>>
25 Best Countries for Retirement Security: 2017
Gary Shilling: Deflation Likely; Fed Completely Clueless
Why Do the Pundits Hate Annuity Commissions?
Wells Fargo has been making fresh headlines over the past week after an attorney working with it shared private information, including Social Security numbers, from 50,000 clients as well as compensation details tied to a group....More>>>
LISTEN TO ARTICLE 1:43 SHARE THIS ARTICLE Facebook Twitter LinkedIn ....More>>>
Stein Mart, Inc. (NASDAQ:SMRT) shares were skyrocketing Friday following the company’s impressive quarterly earnings report Thursday.
The discount department store report fiscal 2017 fourth-quarter earnings at a net loss of $400,000, or a penny per diluted share, narrowing its year-ago net loss of $4.9 million, or 11 cents per share. Operating income for the quarter was $4.1 million,....More>>>
Penny stocks are so attractive thanks to their explosive potential. These stocks trade for just dollars, or even pennies, and can post triple- or even quadruple-digit gains in a matter of days.
Take Marathon Patent Group Inc. (Nasdaq: MARA) for example. Shares of this penny stock soared 341% in just four days during the week of Thanksgiving.
That’s why we’re bringing....More>>>
Marathon Patent Group Inc. (Nasdaq: MARA) is among the top penny stocks to watch for December after climbing an astonishing 341% during the short Thanksgiving week.
While that’s a great gain, we’re recommending a different stock to our readers. This stock is positioned for huge returns and is less volatile.
Instead, the company we’ll show you today is on the....More>>>
Check out the companies making headlines before the bell:
Walmart The retail giant reported adjusted quarterly profit of $1.14 per share, 2 cents share above estimates. Revenue also beat forecasts. US comparable-store sales were up 2.1 percent, beating consensus estimates.
Cisco Systems Cisco reported adjusted quarterly profit of 66 cents per share, a penny a share ahead of estimates.....More>>>
California marijuana stocksare going to benefit from the $20.2 billion sales expected to hit The Golden State.
And that means this could be the last chance to buy marijuana penny stocks before they surge and shed their penny-stock status.
But investors also need to exercise caution before investing in cannabis stocks…
While some investors will be big winners, there....More>>>
If you’re looking for tips on how to make money withpenny stocks today, we have one tip that can help you find the safest companies to invest in.
Investing in penny stocks is popular for one big reason: The shares are inexpensive, usually below $5, so you can quickly make triple-digit profits. Biotech penny stock Oncobiologics Inc. (Nasdaq: ONS) soared from $0.87 to $1.89 between....More>>>
Last week’s best-performing penny stock was Cartesian Inc. (OTCMKTS: CRTN), a management consulting company that locked in an explosive gain of over 170%. That shows there’s still money to be made in stocks even as the market lost $768 billion last week, which is why we’re bringing you top penny stock to watch this week.
Last Wednesday (March 21), Cartesian stock rocketed....More>>>
Hospitals may soon have to post their standard prices for patients online, under a proposed rule unveiled Tuesday by the Trump administration.
Also, the administration is seeking comments on how to stop so-called surprise billing — when patients are charged after unknowingly being seen by out-of-network providers — and how to give patients better information about the out-of-pocket....More>>>
As you're likely aware, the stock market doesn't go up in a straight line -- even if 2017 sort of made it feel like it did. The stock market regularly goes through corrections, some of which will turn into bear markets. This is an inevitable part of investing, and the price of admission if you
American Republic Agrees to Acquire Funeral Insurer
5 Peeks at a Hot New Variable Annuity Guarantee Paper
4 Ways New York May Make DOL Look Like a Fiduciary Kitten
Drugmakers can provide free medication to patients who can’t afford their prescriptions after a major indu
The annual American Society of Clinical Oncology Conference kicks off Friday, June 1, 2018.Every year, thousands of healthcare professionals, scientists, and investors assemble in Chicago to hear about the latest scientific breakthroughs redefining cancer care. Over the course of this five-day co
In the part 1, part 2, and part 3 of the series, I have discussed growth drivers and on-going research programs for Celgene's (NASDAQ:CELG) key oncology products, Revlimid and Pomalyst. Beyond hematologic oncology, however, Celgene also has a strong presence in the solid tumor segment.
Cel
It is no secret that Celgene (NASDAQ:CELG) is thriving while improving the lives of patients with cancer and autoimmune diseases in the United States and around the world.
Celgene's recent outstanding performance has primarily been on the back of its workhorse, REVLIMID (lenalidomide), use
Here's Advertisement